Relapse Multiple Myeloma Clinical Trials in Boston, Massachusetts
4 recruitingBoston, Massachusetts
Showing 1–4 of 4 trials
Recruiting
Phase 2
MMRC Horizon One: RRMM (MMRC-099)
Refractory Multiple MyelomaRelapse Multiple Myeloma
Multiple Myeloma Research Consortium300 enrolled13 locationsNCT06171685
Recruiting
Phase 1
A Phase 1 Study of Vaccination With Dendritic Cell (DC)/Multiple Myeloma (MM) Fusions in Combination With Elranatamab in Relapsed or Refractory Multiple Myeloma
Multiple MyelomaRefractory Multiple MyelomaRelapse Multiple Myeloma
David Avigan25 enrolled2 locationsNCT06799026
Recruiting
Phase 1
DC/MM Fusion Vaccine With BCMA CAR-T in R/R MM
Multiple MyelomaRefractory Multiple MyelomaRelapse Multiple Myeloma
David Avigan25 enrolled1 locationNCT07377435
Recruiting
Phase 2
Elranatamab in R/R Multiple Myeloma
Multiple MyelomaRefractory Multiple MyelomaRelapse Multiple Myeloma
Massachusetts General Hospital32 enrolled3 locationsNCT06138275